It is probably high in the scale, bearing in mind the diversity of known and potential risk factors referred to above. In short, there may a hundred or more genes contributing to risk in diseases such as ARM or AMD.
The goals are to identify those with large marginal effects on disease risk, or to identify variants with smaller marginal effects but which are common in the population, and so contribute disproportionately to the population attributable risk (i.e. the extent to which disease prevalence declines if these are hypothetically eliminated from the population).16 Both goals offer a means of identifying novel mechanisms or pathways which could lead to new therapeutic approaches.
The approximate population prevalence of various common disorders in the United States population is shown in Table 1 , where it can be seen that ARM affects almost two orders of magnitude more people than the monogenic disorder RP. Why is it so common? The most obvious answer is that it is a disorder of ageing, since disease rates increase exponentially with age. It follows from this that ARM is genetically influenced, to the extent that ageing reflects our innate ability to combat the entropic effects of age, a genetic property of each species.
This does not imply that genetic differences between individuals account for disease variability in the population. One study of ageing in Bruch's membrane suggests that if we were all to live to age 120 years, we would all have ARM.1 7 The ageing process is genetically Table 2 , but it is unclear whether these just represent the few cherries that happen to have fallen from the tree, while the majority remain well out of reach?l The allele frequencies of such variants tend to vary in a gradual fashion across ethnic groups, which may go some way towards explaining ethnic differences in disease prevalence. The importance of the distinction between a small number of common variants influencing disease and a large number of rare variants at many genes is important in devising a mapping strategy to detect genes of small or intermediate effect.
Gene mapping strategies
Genetic mapping exploits a variety of strategies to enrich for disease susceptibility genes in a patient or disease risk group (for simplicity, this will be referred to as the There are several strategies which aim to increase the frequency and enrichment for a risk allele in a complex disease population. The most obvious is to choose probands (i) with a strong family history of disease, or of disease determinants (the major strategy used to enrich for rare monogenic disease genes). This increases the chance that probands have a common disease risk allele rather than non-genetic phenocopies of the disease.
Other strategies relevant to ARM! AMD include choosing probands (ii) with early onset of disease (e.g. Table 2 ). 
